{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:10:52Z","timestamp":1793254252534,"version":"4.5.0"},"reference-count":81,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2022.12910","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T11:41:21Z","timestamp":1653306081000},"page":"e2212910","source":"Crossref","is-referenced-by-count":196,"title":["Association of Alzheimer Disease With Life Expectancy in People With Down Syndrome"],"prefix":"10.1001","volume":"5","author":[{"given":"Maria Florencia","family":"Iulita","sequence":"first","affiliation":[{"name":"Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Center of Biomedical Investigation Network for Neurodegenerative Diseases, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Garz\u00f3n Chavez","sequence":"additional","affiliation":[{"name":"Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Center of Biomedical Investigation Network for Neurodegenerative Diseases, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Klitgaard Christensen","sequence":"additional","affiliation":[{"name":"National Centre for Register-based Research, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Valle Tamayo","sequence":"additional","affiliation":[{"name":"Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Center of Biomedical Investigation Network for Neurodegenerative Diseases, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleguer","family":"Plana-Ripoll","sequence":"additional","affiliation":[{"name":"National Centre for Register-based Research, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja A.","family":"Rasmussen","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics and Obstetrics and Gynecology, University of Florida College of Medicine, Gainesville, Florida"},{"name":"Department of Epidemiology, University of Florida College of Public Health and Health Professions and College of Medicine, Gainesville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Roqu\u00e9 Figuls","sequence":"additional","affiliation":[{"name":"Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Alcolea","sequence":"additional","affiliation":[{"name":"Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Center of Biomedical Investigation Network for Neurodegenerative Diseases, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Videla","sequence":"additional","affiliation":[{"name":"Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Center of Biomedical Investigation Network for Neurodegenerative Diseases, Madrid, Spain"},{"name":"Barcelona Down Medical Center, Fundaci\u00f3 Catalana S\u00edndrome de Down, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Barroeta","sequence":"additional","affiliation":[{"name":"Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Center of Biomedical Investigation Network for Neurodegenerative Diseases, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bessy","family":"Benejam","sequence":"additional","affiliation":[{"name":"Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Center of Biomedical Investigation Network for Neurodegenerative Diseases, Madrid, Spain"},{"name":"Barcelona Down Medical Center, Fundaci\u00f3 Catalana S\u00edndrome de Down, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miren","family":"Altuna","sequence":"additional","affiliation":[{"name":"Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Center of Biomedical Investigation Network for Neurodegenerative Diseases, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concepci\u00f3n","family":"Padilla","sequence":"additional","affiliation":[{"name":"Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Center of Biomedical Investigation Network for Neurodegenerative Diseases, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Pegueroles","sequence":"additional","affiliation":[{"name":"Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Center of Biomedical Investigation Network for Neurodegenerative Diseases, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Fernandez","sequence":"additional","affiliation":[{"name":"Barcelona Down Medical Center, Fundaci\u00f3 Catalana S\u00edndrome de Down, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Belbin","sequence":"additional","affiliation":[{"name":"Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Center of Biomedical Investigation Network for Neurodegenerative Diseases, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Carmona-Iragui","sequence":"additional","affiliation":[{"name":"Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Center of Biomedical Investigation Network for Neurodegenerative Diseases, Madrid, Spain"},{"name":"Barcelona Down Medical Center, Fundaci\u00f3 Catalana S\u00edndrome de Down, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Blesa","sequence":"additional","affiliation":[{"name":"Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Center of Biomedical Investigation Network for Neurodegenerative Diseases, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Lle\u00f3","sequence":"additional","affiliation":[{"name":"Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Center of Biomedical Investigation Network for Neurodegenerative Diseases, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Bejanin","sequence":"additional","affiliation":[{"name":"Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Center of Biomedical Investigation Network for Neurodegenerative Diseases, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Fortea","sequence":"additional","affiliation":[{"name":"Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Center of Biomedical Investigation Network for Neurodegenerative Diseases, Madrid, Spain"},{"name":"Barcelona Down Medical Center, Fundaci\u00f3 Catalana S\u00edndrome de Down, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,5,23]]},"reference":[{"issue":"4","key":"zoi220378r1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/gim.2016.127","article-title":"Estimation of the number of people with Down syndrome in the United States.","volume":"19","author":"de Graaf","year":"2017","journal-title":"Genet Med"},{"issue":"3","key":"zoi220378r2","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41431-020-00748-y","article-title":"Estimation of the number of people with Down syndrome in Europe.","volume":"29","author":"de Graaf","year":"2021","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"zoi220378r3","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/ajmg.a.v176.1","article-title":"Co-occurring medical conditions in adults with Down syndrome: a systematic review toward the development of health care guidelines.","volume":"176","author":"Capone","year":"2018","journal-title":"Am J Med Genet A"},{"issue":"9311","key":"zoi220378r4","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0140-6736(02)08092-3","article-title":"Mortality associated with Down\u2019s syndrome in the USA from 1983 to 1997: a population-based study.","volume":"359","author":"Yang","year":"2002","journal-title":"Lancet"},{"issue":"4","key":"zoi220378r5","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.jpeds.2013.06.013","article-title":"Current estimate of Down Syndrome population prevalence in the United States.","volume":"163","author":"Presson","year":"2013","journal-title":"J Pediatr"},{"issue":"9","key":"zoi220378r6","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/jir.v61.9","article-title":"A prospective 20-year longitudinal follow-up of dementia in persons with Down syndrome.","volume":"61","author":"McCarron","year":"2017","journal-title":"J Intellect Disabil Res"},{"issue":"8","key":"zoi220378r7","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1093\/brain\/awy159","article-title":"Trisomy of human chromosome 21 enhances amyloid-\u00df deposition independently of an extra copy of APP.","volume":"141","author":"Wiseman","year":"2018","journal-title":"Brain"},{"issue":"2","key":"zoi220378r8","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3233\/JAD-160836","article-title":"Down Syndrome, partial trisomy 21, and absence of Alzheimer\u2019s disease: the role of APP.","volume":"56","author":"Doran","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"zoi220378r9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0047-6374(88)90041-3","article-title":"The pathological association between Down syndrome and Alzheimer disease.","volume":"43","author":"Mann","year":"1988","journal-title":"Mech Ageing Dev"},{"issue":"10242","key":"zoi220378r10","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/S0140-6736(20)30689-9","article-title":"Clinical and biomarker changes of Alzheimer\u2019s disease in adults with Down syndrome: a cross-sectional study.","volume":"395","author":"Fortea","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"zoi220378r11","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria.","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol"},{"issue":"11","key":"zoi220378r12","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/S1474-4422(21)00245-3","article-title":"Alzheimer\u2019s disease associated with Down syndrome: a genetic form of dementia.","volume":"20","author":"Fortea","year":"2021","journal-title":"Lancet Neurol"},{"issue":"1","key":"zoi220378r13","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.v12.1","article-title":"The Alzheimer\u2019s biomarker consortium-Down syndrome: rationale and methodology.","volume":"12","author":"Handen","year":"2020","journal-title":"Alzheimers Dement (Amst)"},{"key":"zoi220378r14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0074-7750(08)00004-9","article-title":"Alzheimer\u2019s disease in adults with Down syndrome.","volume":"36","author":"Zigman","year":"2008","journal-title":"Int Rev Res Ment Retard"},{"issue":"6","key":"zoi220378r15","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/acn3.2018.5.issue-6","article-title":"Aging related cognitive changes associated with Alzheimer\u2019s disease in Down syndrome.","volume":"5","author":"Firth","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"zoi220378r16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4172\/2472-1115","article-title":"Beyond trisomy 21: phenotypic variability in people with Down syndrome explained by further chromosome mis-segregation and mosaic aneuploidy.","volume":"2","author":"Potter","year":"2016","journal-title":"J Down Syndr Chromosom Abnorm"},{"issue":"1","key":"zoi220378r17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1192\/apt.10.1.50","article-title":"Down\u2019s syndrome and dementia.","volume":"10","author":"Stanton","year":"2004","journal-title":"Adv Psychiatr Treat"},{"issue":"3","key":"zoi220378r18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/(ISSN)1098-2779","article-title":"Alzheimer\u2019s disease in Down syndrome: neurobiology and risk.","volume":"13","author":"Zigman","year":"2007","journal-title":"Ment Retard Dev Disabil Res Rev"},{"issue":"5","key":"zoi220378r19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154596","article-title":"Developing an informant questionnaire for cognitive abilities in Down syndrome: the cognitive scale for Down syndrome (CS-DS).","volume":"11","author":"Startin","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"zoi220378r20","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1212\/WNL.0000000000000596","article-title":"Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis.","volume":"83","author":"Ryman","year":"2014","journal-title":"Neurology"},{"issue":"4","key":"zoi220378r21","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/alz.v17.4","article-title":"Biphasic cortical macro- and microstructural changes in autosomal dominant Alzheimer\u2019s disease.","volume":"17","author":"Montal","year":"2021","journal-title":"Alzheimers Dement"},{"key":"zoi220378r22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1741-7015-2-13","article-title":"A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology.","volume":"2","author":"McGrath","year":"2004","journal-title":"BMC Med"},{"issue":"11","key":"zoi220378r24","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/(ISSN)1097-0258","article-title":"Quantifying heterogeneity in a meta-analysis.","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"4","key":"zoi220378r26","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/ajmg.a.v161.4","article-title":"Changes in mortality and causes of death in the Swedish Down syndrome population.","volume":"161A","author":"Englund","year":"2013","journal-title":"Am J Med Genet A"},{"issue":"4","key":"zoi220378r27","doi-asserted-by":"publisher","DOI":"10.1016\/j.dhjo.2020.100947","article-title":"Cause of death in adults with Down syndrome in the United States.","volume":"13","author":"Landes","year":"2020","journal-title":"Disabil Health J"},{"issue":"4","key":"zoi220378r28","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1176\/ajp.156.4.564","article-title":"MRI volumes of the hippocampus and amygdala in adults with Down\u2019s syndrome with and without dementia.","volume":"156","author":"Aylward","year":"1999","journal-title":"Am J Psychiatry"},{"issue":"Pt 1","key":"zoi220378r29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1348\/014466507X230967","article-title":"Executive dysfunction and its association with personality and behaviour changes in the development of Alzheimer\u2019s disease in adults with Down syndrome and mild to moderate learning disabilities.","volume":"47","author":"Ball","year":"2008","journal-title":"Br J Clin Psychol"},{"issue":"11","key":"zoi220378r30","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1001\/jamaneurol.2018.2210","article-title":"Prevalence of aging, dementia, and multimorbidity in older adults with Down syndrome.","volume":"75","author":"Bayen","year":"2018","journal-title":"JAMA Neurol"},{"issue":"Pt 2","key":"zoi220378r31","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/(ISSN)1365-2788","article-title":"Epilepsy, dementia and adaptive behaviour in Down\u2019s syndrome.","volume":"37","author":"Collacott","year":"1993","journal-title":"J Intellect Disabil Res"},{"issue":"2","key":"zoi220378r32","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3233\/JAD-2010-1247","article-title":"Early age at menopause is associated with increased risk of dementia and mortality in women with Down syndrome.","volume":"19","author":"Coppus","year":"2010","journal-title":"J Alzheimers Dis"},{"issue":"Pt 10","key":"zoi220378r33","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/jir.2006.50.issue-10","article-title":"Dementia and mortality in persons with Down\u2019s syndrome.","volume":"50","author":"Coppus","year":"2006","journal-title":"J Intellect Disabil Res"},{"issue":"6","key":"zoi220378r34","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.neurobiolaging.2006.12.013","article-title":"The impact of apolipoprotein E on dementia in persons with Down\u2019s syndrome.","volume":"29","author":"Coppus","year":"2008","journal-title":"Neurobiol Aging"},{"issue":"9","key":"zoi220378r35","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.neurobiolaging.2011.08.007","article-title":"Plasma \u00df amyloid and the risk of Alzheimer\u2019s disease in Down syndrome.","volume":"33","author":"Coppus","year":"2012","journal-title":"Neurobiol Aging"},{"issue":"1","key":"zoi220378r36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1017\/S0790966700003943","article-title":"A five year follow-up study of dementia in persons with Down\u2019s syndrome: early symptoms and patterns of deterioration.","volume":"17","author":"Cosgrave","year":"2000","journal-title":"Ir J Psychol Med"},{"key":"zoi220378r37","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1192\/bjp.176.5.468","article-title":"APOE epsilon 4 influences the manifestation of Alzheimer\u2019s disease in adults with Down\u2019s syndrome.","volume":"176","author":"Deb","year":"2000","journal-title":"Br J Psychiatry"},{"issue":"Pt 6","key":"zoi220378r38","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/jir.2000.44.issue-6","article-title":"Sequence of cognitive decline in dementia in adults with Down\u2019s syndrome.","volume":"44","author":"Devenny","year":"2000","journal-title":"J Intellect Disabil Res"},{"issue":"3","key":"zoi220378r39","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1001\/archneur.1990.00530030029011","article-title":"The natural history of dementia in Down\u2019s syndrome.","volume":"47","author":"Evenhuis","year":"1990","journal-title":"Arch Neurol"},{"key":"zoi220378r40","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.neurobiolaging.2019.02.028","article-title":"Frontal-subcortical behaviors during Alzheimer\u2019s disease in individuals with Down syndrome.","volume":"78","author":"Fonseca","year":"2019","journal-title":"Neurobiol Aging"},{"issue":"2","key":"zoi220378r41","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1001\/jamaneurol.2018.3616","article-title":"Association of dementia with mortality among adults with Down syndrome older than 35 years.","volume":"76","author":"Hithersay","year":"2019","journal-title":"JAMA Neurol"},{"issue":"1","key":"zoi220378r42","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/00001756-199310000-00005","article-title":"Reduced transferrin binding in Down syndrome: a route to senile plaque formation and dementia.","volume":"5","author":"Hodgkins","year":"1993","journal-title":"Neuroreport"},{"issue":"3","key":"zoi220378r43","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1352\/0047-6765(2000)038<0276:PODAIO>2.0.CO;2","article-title":"Prevalence of dementia and impact on intellectual disability services.","volume":"38","author":"Janicki","year":"2000","journal-title":"Ment Retard"},{"key":"zoi220378r44","article-title":"An intron 7 polymorphism in app affects the age of onset of dementia in Down syndrome.","volume":"2011","author":"Jones","year":"2010","journal-title":"Int J Alzheimers Dis"},{"issue":"5","key":"zoi220378r45","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1352\/2008.113:369-386","article-title":"Selective attention deficits associated with mild cognitive impairment and early stage Alzheimer\u2019s disease in adults with Down syndrome.","volume":"113","author":"Krinsky-McHale","year":"2008","journal-title":"Am J Ment Retard"},{"issue":"Pt 3","key":"zoi220378r46","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1046\/j.1365-2788.2002.00365.x","article-title":"Changes in explicit memory associated with early dementia in adults with Down\u2019s syndrome.","volume":"46","author":"Krinsky-McHale","year":"2002","journal-title":"J Intellect Disabil Res"},{"issue":"2","key":"zoi220378r47","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1212\/WNL.53.2.331","article-title":"APOE genotype and gender effects on Alzheimer disease in 100 adults with Down syndrome.","volume":"53","author":"Lai","year":"1999","journal-title":"Neurology"},{"issue":"1","key":"zoi220378r48","article-title":"Sex differences in risk of Alzheimer\u2019s disease in adults with Down syndrome.","volume":"12","author":"Lai","year":"2020","journal-title":"Alzheimers Dement (Amst)"},{"issue":"8","key":"zoi220378r49","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/archneur.1989.00520440031017","article-title":"A prospective study of Alzheimer disease in Down syndrome.","volume":"46","author":"Lai","year":"1989","journal-title":"Arch Neurol"},{"issue":"6","key":"zoi220378r50","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/ana.25905","article-title":"Alzheimer-related cerebrovascular disease in Down syndrome.","volume":"88","author":"Lao","year":"2020","journal-title":"Ann Neurol"},{"key":"zoi220378r51","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/361218","article-title":"Polymorphisms in HSD17B1: early onset and increased risk of Alzheimer\u2019s Disease in women with Down syndrome.","volume":"2012","author":"Lee","year":"2012","journal-title":"Curr Gerontol Geriatr Res"},{"key":"zoi220378r52","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.nicl.2016.06.001","article-title":"(1)H-MRS metabolites in adults with Down syndrome: effects of dementia.","volume":"11","author":"Lin","year":"2016","journal-title":"Neuroimage Clin"},{"issue":"11","key":"zoi220378r53","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1212\/01.WNL.0000129275.13169.BE","article-title":"Influence of the amyloid precursor protein locus on dementia in Down syndrome.","volume":"62","author":"Margallo-Lana","year":"2004","journal-title":"Neurology"},{"issue":"Pt. 6","key":"zoi220378r54","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2788.2006.00902.x","article-title":"Fifteen-year follow-up of 92 hospitalized adults with Down\u2019s syndrome: incidence of cognitive decline, its relationship to age and neuropathology.","volume":"51","author":"Margallo-Lana","year":"2007","journal-title":"J Intellect Disabil Res"},{"issue":"11","key":"zoi220378r55","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/00001756-199507310-00012","article-title":"ApoE genotypes in Australia: roles in early and late onset Alzheimer\u2019s disease and Down\u2019s syndrome.","volume":"6","author":"Martins","year":"1995","journal-title":"Neuroreport"},{"issue":"3","key":"zoi220378r56","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3233\/JAD-142514","article-title":"Serum NGAL is associated with distinct plasma amyloid-\u00df peptides according to the clinical diagnosis of dementia in Down syndrome.","volume":"45","author":"Naud\u00e9","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"12","key":"zoi220378r57","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/gps.930101213","article-title":"End-stage dementia in adults with Down syndrome.","volume":"10","author":"Prasher","year":"1995","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1","key":"zoi220378r58","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1352\/0895-8017(1998)103<0040:LCIABI>2.0.CO;2","article-title":"Longitudinal changes in adaptive behavior in adults with Down syndrome: interim findings from a longitudinal study.","volume":"103","author":"Prasher","year":"1998","journal-title":"Am J Ment Retard"},{"issue":"Pt 5","key":"zoi220378r59","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2788.1995.tb00547.x","article-title":"Behavioural disturbance in people with Down\u2019s syndrome and dementia.","volume":"39","author":"Prasher","year":"1995","journal-title":"J Intellect Disabil Res"},{"issue":"11","key":"zoi220378r60","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/gps.2039","article-title":"Significant effect of APOE epsilon 4 genotype on the risk of dementia in Alzheimer\u2019s disease and mortality in persons with Down syndrome.","volume":"23","author":"Prasher","year":"2008","journal-title":"Int J Geriatr Psychiatry"},{"issue":"79","key":"zoi220378r61","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1179\/bjdd.1994.016","article-title":"Down syndrome, dementia and macrocytosis.","volume":"40","author":"Prasher","year":"1994","journal-title":"Br J Dev Disabil"},{"issue":"11","key":"zoi220378r62","first-page":"1393","article-title":"Gender differences in the phenotypic expression of Alzheimer\u2019s disease in Down\u2019s syndrome (trisomy 21).","volume":"5","author":"Raghavan","year":"1994","journal-title":"Neuroreport"},{"issue":"18","key":"zoi220378r63","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1097\/00001756-199412000-00044","article-title":"Apolipoprotein E epsilon 2 allele promotes longevity and protects patients with Down\u2019s syndrome from dementia.","volume":"5","author":"Royston","year":"1994","journal-title":"Neuroreport"},{"issue":"5","key":"zoi220378r64","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1159\/000126495","article-title":"Estrogen receptor-alpha variants increase risk of Alzheimer\u2019s disease in women with Down syndrome.","volume":"25","author":"Schupf","year":"2008","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"3","key":"zoi220378r65","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0304-3940(01)01657-3","article-title":"Elevated plasma amyloid beta-peptide 1-42 and onset of dementia in adults with Down syndrome.","volume":"301","author":"Schupf","year":"2001","journal-title":"Neurosci Lett"},{"issue":"3","key":"zoi220378r66","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.neulet.2006.07.062","article-title":"Bioavailable estradiol and age at onset of Alzheimer\u2019s disease in postmenopausal women with Down syndrome.","volume":"406","author":"Schupf","year":"2006","journal-title":"Neurosci Lett"},{"issue":"4","key":"zoi220378r67","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000007940","article-title":"Prevalence of dementia of Alzheimer type and apolipoprotein E phenotypes in aged patients with Down\u2019s syndrome.","volume":"39","author":"Sekijima","year":"1998","journal-title":"Eur Neurol"},{"issue":"5","key":"zoi220378r68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153917","article-title":"Assessing specific cognitive deficits associated with dementia in older adults with Down syndrome: use and validity of the arizona cognitive test battery (ACTB).","volume":"11","author":"Sinai","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"zoi220378r69","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3233\/JAD-170624","article-title":"Predictors of age of diagnosis and survival of Alzheimer\u2019s disease in Down syndrome.","volume":"61","author":"Sinai","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"zoi220378r70","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jalz.2018.08.009","article-title":"Cognitive markers of preclinical and prodromal Alzheimer\u2019s disease in Down syndrome.","volume":"15","author":"Startin","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"7","key":"zoi220378r71","doi-asserted-by":"crossref","first-page":"731","DOI":"10.4088\/JCP.13m08562","article-title":"Effects of antidepressants on longevity and dementia onset among adults with Down syndrome: a retrospective study.","volume":"75","author":"Tsiouris","year":"2014","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"zoi220378r72","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/gps.502","article-title":"Dementia in people with Down\u2019s syndrome.","volume":"16","author":"Tyrrell","year":"2001","journal-title":"Int J Geriatr Psychiatry"},{"issue":"3","key":"zoi220378r73","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1017\/ipm.2016.1","article-title":"The challenges of diagnosis and treatment of dementia in Down\u2019s syndrome.","volume":"33","author":"Vaughan","year":"2016","journal-title":"Ir J Psychol Med"},{"issue":"4","key":"zoi220378r74","first-page":"400","article-title":"Prospective study of the prevalence of Alzheimer-type dementia in institutionalized individuals with Down syndrome.","volume":"101","author":"Visser","year":"1997","journal-title":"Am J Ment Retard"},{"issue":"7","key":"zoi220378r75","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1212\/WNL.35.7.957","article-title":"Alzheimer\u2019s disease in Down\u2019s syndrome: clinicopathologic studies.","volume":"35","author":"Wisniewski","year":"1985","journal-title":"Neurology"},{"issue":"4","key":"zoi220378r76","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000334522","article-title":"Estrogen receptor-beta variants are associated with increased risk of Alzheimer\u2019s disease in women with down syndrome.","volume":"32","author":"Zhao","year":"2011","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"3","key":"zoi220378r77","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neulet.2007.02.023","article-title":"Cholesterol level, statin use and Alzheimer\u2019s disease in adults with Down syndrome.","volume":"416","author":"Zigman","year":"2007","journal-title":"Neurosci Lett"},{"issue":"8","key":"zoi220378r78","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jamaneurol.2021.1893","article-title":"Association of apolipoprotein e ?4 allele with clinical and multimodal biomarker changes of Alzheimer disease in adults with Down syndrome.","volume":"78","author":"Bejanin","year":"2021","journal-title":"JAMA Neurol"},{"issue":"3-4","key":"zoi220378r79","first-page":"99","article-title":"Opportunities, barriers, and recommendations in down syndrome research.","volume":"5","author":"Hendrix","year":"2021","journal-title":"Transl Sci Rare Dis"},{"issue":"6","key":"zoi220378r80","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.jpeds.2006.01.010","article-title":"Survival in infants with Down syndrome, metropolitan Atlanta, 1979-1998.","volume":"148","author":"Rasmussen","year":"2006","journal-title":"J Pediatr"},{"issue":"9","key":"zoi220378r81","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease.","volume":"367","author":"Bateman","year":"2012","journal-title":"N Engl J Med"},{"key":"zoi220378r23","author":"Egger","year":"2001"},{"key":"zoi220378r25","unstructured":"Higgins? JPT, Thomas? J, Chandler? J, . Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Training; 2021. Accessed May 4, 2022. http:\/\/www.training.cochrane.org\/handbook"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2792538\/iulita_2022_oi_220378_1652456872.86845.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T18:31:25Z","timestamp":1675621885000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2792538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,23]]},"references-count":81,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.12910","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,23]]}}}